Company Filing History:
Years Active: 2012-2020
Title: Innovations by Wei-meng Zhao
Introduction
Wei-meng Zhao is a prominent inventor based in Palo Alto, CA. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 6 patents to his name, Zhao's work has the potential to impact various therapeutic applications.
Latest Patents
One of his latest patents focuses on monoclonal antibodies to fibroblast growth factor receptor 2. This invention is directed toward a monoclonal antibody that targets fibroblast growth factor receptor 2, along with a pharmaceutical composition comprising the antibody. The methods of treatment involve administering this pharmaceutical composition to patients, showcasing the therapeutic potential of his work.
Career Highlights
Wei-meng Zhao is currently associated with Galaxy Biotech, LLC, where he continues to innovate and develop new biotechnological solutions. His expertise in monoclonal antibodies has positioned him as a key figure in the industry.
Collaborations
Zhao has collaborated with notable colleagues, including Kyung Jin Kim and Hangil Park, to advance research and development in his field.
Conclusion
Wei-meng Zhao's contributions to biotechnology, particularly through his patents on monoclonal antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.